Strata Critical Medical, Inc.
Company & revenue
About Strata Critical Medical, Inc.
Financial breakdown: year ended 2025-12-31
Who they are
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025.
Brands & revenue mix
Core brand for transplant logistics and clinical services.
Separate brand revenue is not available in this research.Source
Brand for perfusion staffing and equipment solutions for cardiovascular surgery centers.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Customer concentrationPREMIUM
The company does not disclose specific customer concentration figures in its latest annual report, though it notes reliance on contractual relationships with transplant centers, hospitals, and Organ Procurement Organizations (OPOs).
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
63
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
66
Fair
Financial Strength
68
Business Quality / Moat
51
Management
80
Growth Quality
100
Risk / Durability
15
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
71
Fair
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
69/100
Building Historical Record
Model Score 69/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently rates the company as mixed to moderately strong.
At today’s price, the WSS valuation framework currently reads as relatively attractive.
The model outlook is currently moderate.
- •Balance-sheet / debt profile scores strongly
- •Valuation scores attractively
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for SRTA
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can SRTA maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can SRTA fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is SRTA likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •Is SRTA's valuation discount tied to a temporary concern or to a longer-term business risk?
Essential Investment Snapshot
Wall Street Score
63
Opportunity Score
71
Market Cap
$409.3M
P/E Ratio
9.9
EPS
$0.50
52-Week High
$6.50
52-Week Low
$3.95
Beta
2.26
Intrinsic Value
$14.73
Analyst Target
$7.25
Shares Outstanding
82.5M
Total Revenue
$256.0M
Total Debt
$4.3M
Dividend
No current dividend
Liquidation Value / Share
$3.39
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Community Sentiment
0 active · 0 total callsNo personal call yet on SRTA.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
- −Negative free cash flow may increase the need for outside financing and dilution.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
42
Jul 24, 2026
Change
+20.8
points
Current Score
63
Oct 1, 2026
Category Changes
SRTA increased 20.8 points because Valuation improved by 100 points, Buffett improved by 9.7 points.
Positive Contributors
- + Valuation improved by 100 points
- + Buffett improved by 9.7 points
Projected Score
Projected Score
61
Projected Change
-1.2%
Preliminary comparable-period financial changes suggest decline of approximately 1.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$4.73
Intrinsic Value
$14.73
Difference
−$10.00
-67.9% vs IV
Margin of Safety
67.9%
Related Companies
Medical - Care FacilitiesNews
Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial